Brief: Rezolute Completes Enrollment Of Its Phase 2 Study In Diabetic Macular Edema

Rezolute

13/12/2023 13:38

Dec 13 (Reuters) - Rezolute Inc  RZLT.O :
    * REZOLUTE COMPLETES ENROLLMENT OF ITS PHASE 2 STUDY IN
DIABETIC
MACULAR EDEMA (“DME”)
    * : COMPANY NOW PLANS TO REPORT TOPLINE RESULTS IN MIDDLE OF
Q2
2024, RATHER THAN END OF Q1 2024

Source text for Eikon:  ID:nGNXbwN9Vm 
Further company coverage:  RZLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))